Listar por tema "Mutations"

Ordenar por:Orden:Resultados:

  • Ramirez-Salinas, Gema L.; Garcia-Machorro, J.; Quiliano, Miguel; Zimic-Peralta, Mirko Juan; Briz, Veronica; Rojas-Hernandez, Saul; Correa-Basurto, J. (Springer, 2015)
    The goal of this study was to identify neuraminidase (NA) residue mutants from human influenza AH1N1 using sequences from 1918 to 2012. Multiple alignment studies of complete NA sequences (5732) were performed. Subsequently, ...
  • Sheen Cortavarria, Patricia; Requena, David; Gushiken, Eduardo; Gilman, Robert Hugh; Antiparra, Ricardo; Lucero, Bryan; Lizárraga, Pilar; Cieza, Basilio; Roncal, Elisa; Grandjean, Louis; Pain, Arnab; McNerney, Ruth; Clark, Taane G.; Moore, David Alexander James; Zimic-Peralta, Mirko Juan (BioMed Central, 2017)
    BACKGROUND: Tuberculosis (TB) is a major global health problem and drug resistance compromises the efforts to control this disease. Pyrazinamide (PZA) is an important drug used in both first and second line treatment ...
  • Reichmuth, M.L.; Hömke, R.; Zürcher, K.; Sander, P.; Avihingsanon, A.; Collantes, J.; Loiseau, C.; Borrell, S.; Reinhard, M.; Wilkinson, R.J.; Yotebieng, M.; Fenner, L.; Böttger, E.C.; Gagneux, S.; Egger, M.; Keller, P.M.; International epidemiology Databases to Evaluate AIDS (IeDEA) (American Society for Microbiology, 2020)
    Mutations in the genes of the F420 signaling pathway of Mycobacterium tuberculosis complex, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, can lead to delamanid resistance. We searched for such mutations among 129 M. ...

Buscar en el Repositorio

Listar

Panel de Control